Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mascha Binder

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 17, 2024
The contribution of SARS-CoV-2 to the burden of acute respiratory infections in winter season 2022/2023: results from the DigiHero studyNadine Glaser, Sophie Diexer, Bianca Klee, et al.
International Journal of Cancer|September 29, 2011
Anti-tumor activity of a B-cell receptor-targeted peptide in a novel disseminated lymphoma xenograft modelClaudia Wehr, Fabian Müller, Julia Schüler, et al.
Journal of Medical Virology|December 2, 2022
Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Bjpsych Open|April 14, 2023
Mental health in Germany in the first weeks of the Russo-Ukrainian warCornelia Gottschick, Sophie Diexer, Janka Massag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2020
Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in GlioblastomaMalte Mohme, Cecile L Maire, Ulf Geumann, et al.
Annals of Hematology|December 20, 2012
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapyAnthony Oyekunle, Axel R Zander, Mascha Binder, et al.
NPJ Precision Oncology|August 5, 2025
Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancerLisa Paschold, Christoph Schultheiss, Paul Schmidt-Barbo, et al.
Cancer Medicine|February 13, 2023
No association of malignant B-cell non-Hodgkin lymphomas with ipsilateral SARS-CoV-2 vaccinationLuise Victoria Claaß, Patrick Mayr, Lisa Paschold, et al.
Blood Advances|February 10, 2023
Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcomeChristiane Katzerke, Judith Schaffrath, Jana Lützkendorf, et al.
Frontiers in Oncology|February 22, 2024
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trialAnna Brandt, Christoph Schultheiss, Konrad Klinghammer, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 17, 2024
The contribution of SARS-CoV-2 to the burden of acute respiratory infections in winter season 2022/2023: results from the DigiHero studyNadine Glaser, Sophie Diexer, Bianca Klee, et al.
International Journal of Cancer|September 29, 2011
Anti-tumor activity of a B-cell receptor-targeted peptide in a novel disseminated lymphoma xenograft modelClaudia Wehr, Fabian Müller, Julia Schüler, et al.
Journal of Medical Virology|December 2, 2022
Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Bjpsych Open|April 14, 2023
Mental health in Germany in the first weeks of the Russo-Ukrainian warCornelia Gottschick, Sophie Diexer, Janka Massag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2020
Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in GlioblastomaMalte Mohme, Cecile L Maire, Ulf Geumann, et al.
Annals of Hematology|December 20, 2012
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapyAnthony Oyekunle, Axel R Zander, Mascha Binder, et al.
NPJ Precision Oncology|August 5, 2025
Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancerLisa Paschold, Christoph Schultheiss, Paul Schmidt-Barbo, et al.
Cancer Medicine|February 13, 2023
No association of malignant B-cell non-Hodgkin lymphomas with ipsilateral SARS-CoV-2 vaccinationLuise Victoria Claaß, Patrick Mayr, Lisa Paschold, et al.
Blood Advances|February 10, 2023
Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcomeChristiane Katzerke, Judith Schaffrath, Jana Lützkendorf, et al.
Frontiers in Oncology|February 22, 2024
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trialAnna Brandt, Christoph Schultheiss, Konrad Klinghammer, et al.
Pageof 15